APOA1 and Alzheimer disease: The results revealed that peripheral blood ApoA-I levels in AD patients were significantly decreased compared with that in HCs [SMD = −1.15; 95% CI (−1.63, −0.66); P = 0.000; Figure 4], in addition to high heterogeneity among these studies (I2 = 96.0%, P = 0.000).